Patient P-02683
Synthetic patientMETA-24 · Day 137 · 25–34 · M · baseline S13Steering view · 3DOpen companion preview
Therapy response
Declining
Tolerance
Deteriorating
GI state
Improving
Inflammatory state
Favorable
Nutritional resilience
Stable
Discontinuation risk
21%
Trajectory
Baseline → today → 30-day prediction · hover a day for signals and eventssolid = observed · dashed = predicted
- Day 0 META-24 started — Baseline state S13
- Day 74 GI-04 recommended — GI Support Protocol GI-04
- Day 75 Patient declined — Not now
- Day 86 Trajectory diverged from prediction — Observed response fell below the model's expected path.
What changed?
Trajectory began diverging from predicted response on Day 86.
Primary contributors, last 14 days
- Treatment adherence+11
- Toxicity+10
- GI instability-4
- Nutritional resilience+4
What helped?
- GI Support Protocol GI-04Day 74Declined by patient
LIFE OS recommendation
No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.
Daily trackers
Molecule settingsThe trackers this program marks as important, last 14 days vs the 14 before.
Active minutes
Wearable83 min
stable · +0.2 vs previous 14 d
Sleep duration
Wearable6.9 h
stable · -0.1 vs previous 14 d
Energy level
Daily log5.3/10
worsening · -0.3 vs previous 14 d
Steps
Wearable9,213
stable · -187 vs previous 14 d
GI burden
Companion30.8/100
worsening · +4.9 vs previous 14 d
Adherence
Companion100 %
improving · +5.9 vs previous 14 d
Sleep quality
Wearable42.6/100
worsening · -3.0 vs previous 14 d
Glucose, CGM daily mean
CGM140 mg/dL
stable · +3.9 vs previous 14 d
This trajectory is decaying — what would help, what would not
Steering view →Heading towards failing · 57 from the failing basin, 30 from restoration.
Would help
- No untried action with strong evidence. Compose one from primitives.
- More proteinGI -3.9 next day on high-intake days · n 26
Would not help
- Keep simple carbs lowGI +2.8 next day on high-intake days · n 19
State influencers · digestive
Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.
- Protein-3.9supporter · 95%
- Simple carbohydrates+2.8detractor · 86%
- Histamine load-1.9no signal · 49%
- Ultra-processed food+1.8no signal · 51%
- Caffeine+1.6no signal · 44%
- Dietary fat load+1.3no signal · 28%
- Alcohol-1.2no signal · 30%
- Insoluble fibre-1no signal · 30%
Biological layers
Which pathways look influenced, and by which layer of this person's biology.
Pathways under pressure
- Butyrate / short-chain fatty acid production ↓25
- MicrobiomeF. prausnitzii depleted
- Autonomic recovery ↓25
- WearableResting HR 78 bpm
- Inflammatory signalling ↓15
- WearableHRV 26 ms, trending down
DNA
Fictional pharmacogenomic panel
- CYP2D6 Normal metabolizerExpected exposure
Microbiome
Shannon diversity 2.9 · butyrate capacity 63/100
- Akkermansia muciniphilaNormal
- Faecalibacterium prausnitziiLow
- Bacteroides fragilisNormal
- Bifidobacterium longumNormal
- EnterobacteriaceaeNormal
Wearable, last 14 days
daily evolution fed into the runtime
- HRV
- 28 ms
- Sleep
- 6.8 h
- Steps
- 9,172
- Resting HR
- 76 bpm
Daily log: GI score 31, nutritional resilience 60, adherence 100.
What this patient sees in NostraAI
The content that steers the trajectory: what to eat, what to do, what to take.
What to eat
- Keep meals regular; three to four moderate portions spaced through the day
- Include a cooked vegetable portion with each main meal
- Add one soluble-fibre source (oats, cooked carrots, banana) to breakfast
- Eat slowly and stop at comfortable fullness — smaller volume, more often
What to do
- Log the daily check-in; one line is enough
- Keep the current walking rhythm
- Keep the sleep window steady
- Keep hydration steady: small amounts through the day rather than large volumes at once
What to take
- Take the dose at the same time relative to your evening meal
- No additional supplements this week
- Fictional demo item: continue vitamin D as before
284 biologically similar trajectories
Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.